Small Cell - The Forgotten Lung Cancer: Limited Stage-Small Cell - The Forgotten Lung Cancer: Limited Stage

Video Transcription

Video Summary

In this webinar, Dr. Gerard Silvestri moderates a discussion on small cell lung cancer (SCLC), with a focus on limited stage disease. Presentations by Dr. Adam Fox, Dr. Mariam Alexander, and Dr. Anurag Singh cover key aspects such as epidemiology, diagnosis, treatment, and advancements in therapy.<br /><br />Dr. Fox outlines the characteristics and rapid progression of SCLC, emphasizing its central location and strong association with smoking. Dr. Singh details the evolution of radiation therapy techniques and their roles in treatment, discussing contrasts between different dosage schedules and highlighting intensity-modulated radiation therapy (IMRT).<br /><br />Dr. Alexander explains the integration of immunotherapy into standard care protocols, citing the ADRIATIC trial that showcases improved outcomes with the addition of durvalumab following concurrent chemoradiation. She underscores the importance of a multidisciplinary team approach and expedited diagnosis and treatment to optimize outcomes.<br /><br />The webinar concludes on an optimistic note about emerging treatments, suggesting that recent advancements in immunotherapy may pave the way for significant improvements in managing both limited and extensive stage SCLC. The importance of comprehensive teamwork in treatment planning is also highlighted.

Keywords

small cell lung cancer

limited stage disease

epidemiology

radiation therapy

immunotherapy

ADRIATIC trial

durvalumab

multidisciplinary team

treatment advancements